股市小六
2025-12-29
这啥时候的新闻了....
诺和诺德,被FDA警告了.....
免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
逐梦飞翔
2025-12-29
逐梦飞翔
这都以前老旧故事了
什么也没有了~
APP内打开
发表看法
1
3
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":516066543514032,"tweetId":"516066543514032","gmtCreate":1767013460271,"gmtModify":1767013462561,"author":{"id":3561532925843785,"idStr":"3561532925843785","authorId":3561532925843785,"authorIdStr":"3561532925843785","name":"股市小六","avatar":"https://static.tigerbbs.com/93351464cd1b89c41fc5f874c63be0d1","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":4,"crmLevelSwitch":1,"individualDisplayBadges":[],"fanSize":7,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"title":"","html":"<html><head></head><body><p>这啥时候的新闻了....</p></body></html>","htmlText":"<html><head></head><body><p>这啥时候的新闻了....</p></body></html>","text":"这啥时候的新闻了....","highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/516066543514032","repostId":2595786805,"repostType":2,"repost":{"id":"2595786805","kind":"news","pubTimestamp":1766998045,"share":"https://www.laohu8.com/m/news/2595786805?lang=zh_CN&edition=full","pubTime":"2025-12-29 16:47","market":"us","language":"zh","title":"诺和诺德,被FDA警告了.....","url":"https://stock-news.laohu8.com/highlight/detail?id=2595786805","media":"MedWorld器械世界","summary":"更严重的是,FDA还指出该工厂缺乏防止微生物污染无菌产品的书面程序,给药品安全埋下了重大隐患。资料显示,诺和诺德在2024年12月才完成对该工厂的收购,而FDA透露,2023年对该工厂的检查中就已发现类似违规行为。目前,诺和诺德尚未公布具体的整改方案和后续进展,作为全球医药行业的标杆企业之一,其工厂的质量问题不仅影响自身品牌声誉。","content":"<html><body><article><p>Medworld器械世界为您提供准确、及时、有效的医疗器械行业及医疗圈的市场动态,产品信息,技术进展等资讯。</p><p>来源:压货大佬</p><p>近期,<strong>全球知名药企<a href=\"https://laohu8.com/S/NVO\">诺和诺德</a>收到了来自FDA(<a href=\"https://laohu8.com/S/USFD\">美国食品</a>药品监督管理局)的警告信</strong>,引发行业关注,这则警告信背后,是药品生产过程中的污染隐患,还牵扯出企业收购后的质量管控难题。</p><p>根据FDA官网信息,警告信发布于2025年12月11日,起因是当年6月23日至7月14日对诺和诺德印第安纳州布卢明顿工厂的专项检查,检查结果显示,<strong>工厂存在20多个未被正确调查的偏差,核心问题是药品可能受到“哺乳动物毛发”污染,具体包括猫毛和人的头发。</strong></p><p>更严重的是,<strong>FDA还指出该工厂缺乏防止微生物污染无菌产品的书面程序,给药品安全埋下了重大隐患。</strong>值得注意的是,这个工厂的问题并非诺和诺德接手后才出现。</p><p>资料显示,诺和诺德在2024年12月才完成对该工厂的收购,而FDA透露,2023年对该工厂的检查中就已发现类似违规行为。</p><p>尽管FDA承认诺和诺德正在向该工厂投入大量资源整改,但仍明确表达了关切:<strong>“在诺和诺德收购之后,可能受污染的药品的释放仍在继续发生。”</strong>这一事件让人<a href=\"https://laohu8.com/S/00992\">联想</a>到拜耳收购孟山都的案例,都是收购前就存在的问题,新东家接手后才集中暴露。</p><p>对于药企而言,收购工厂是拓展产能、布局市场的常见操作,但美国工厂的质量管控风险显然不容小觑,无菌药品的生产标准本就极为严苛,毛发污染看似“小事”,却直接关乎患者用药安全,也考验着企业的品控体系和责任担当。</p><p>目前,诺和诺德尚未公布具体的整改方案和后续进展,作为全球医药行业的标杆企业之一,其工厂的质量问题不仅影响自身品牌声誉。</p><p>也给整个行业敲响了警钟:企业收购并购过程中,除了评估产能、市场等商业价值,更要重视标的资产的质量管控历史和潜在风险,否则再优质的商业布局,也可能因品控漏洞栽跟头,后续整改能否到位、如何杜绝类似问题,值得行业和消费者持续关注。</p></article></body></html>","source":"tencent","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>诺和诺德,被FDA警告了.....</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n诺和诺德,被FDA警告了.....\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-12-29 16:47 北京时间 <a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251229164936a4855a5e&s=b><strong>MedWorld器械世界</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Medworld器械世界为您提供准确、及时、有效的医疗器械行业及医疗圈的市场动态,产品信息,技术进展等资讯。来源:压货大佬近期,全球知名药企诺和诺德收到了来自FDA(美国食品药品监督管理局)的警告信,引发行业关注,这则警告信背后,是药品生产过程中的污染隐患,还牵扯出企业收购后的质量管控难题。根据FDA官网信息,警告信发布于2025年12月11日,起因是当年6月23日至7月14日对诺和诺德印第安纳州...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251229164936a4855a5e&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"IE00BZ1G4Q59.USD":"LEGG MASON CLEARBRIDGE US EQUITY SUSTAINABILITY LEADER \"A\"(USD) INC (A)","IE00BKVL7J92.USD":"Legg Mason ClearBridge - US Equity Sustainability Leaders A Acc USD","BK4588":"碎股","LU0154236417.USD":"BGF US FLEXIBLE EQUITY \"A2\" ACC","BK4585":"ETF&股票定投概念","LU1093756325.SGD":"FTIF - Franklin K2 Alt Strat Fd A (acc) SGD-H1","NVO":"诺和诺德","BK4532":"文艺复兴科技持仓","BK4599":"减肥药","LU1093756168.USD":"FRANKLIN K2 ALTERNATIVE STRATEGIES \"A\" (USD) ACC","BK4007":"制药"},"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251229164936a4855a5e&s=b","is_english":false,"share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","article_id":"2595786805","content_text":"Medworld器械世界为您提供准确、及时、有效的医疗器械行业及医疗圈的市场动态,产品信息,技术进展等资讯。来源:压货大佬近期,全球知名药企诺和诺德收到了来自FDA(美国食品药品监督管理局)的警告信,引发行业关注,这则警告信背后,是药品生产过程中的污染隐患,还牵扯出企业收购后的质量管控难题。根据FDA官网信息,警告信发布于2025年12月11日,起因是当年6月23日至7月14日对诺和诺德印第安纳州布卢明顿工厂的专项检查,检查结果显示,工厂存在20多个未被正确调查的偏差,核心问题是药品可能受到“哺乳动物毛发”污染,具体包括猫毛和人的头发。更严重的是,FDA还指出该工厂缺乏防止微生物污染无菌产品的书面程序,给药品安全埋下了重大隐患。值得注意的是,这个工厂的问题并非诺和诺德接手后才出现。资料显示,诺和诺德在2024年12月才完成对该工厂的收购,而FDA透露,2023年对该工厂的检查中就已发现类似违规行为。尽管FDA承认诺和诺德正在向该工厂投入大量资源整改,但仍明确表达了关切:“在诺和诺德收购之后,可能受污染的药品的释放仍在继续发生。”这一事件让人联想到拜耳收购孟山都的案例,都是收购前就存在的问题,新东家接手后才集中暴露。对于药企而言,收购工厂是拓展产能、布局市场的常见操作,但美国工厂的质量管控风险显然不容小觑,无菌药品的生产标准本就极为严苛,毛发污染看似“小事”,却直接关乎患者用药安全,也考验着企业的品控体系和责任担当。目前,诺和诺德尚未公布具体的整改方案和后续进展,作为全球医药行业的标杆企业之一,其工厂的质量问题不仅影响自身品牌声誉。也给整个行业敲响了警钟:企业收购并购过程中,除了评估产能、市场等商业价值,更要重视标的资产的质量管控历史和潜在风险,否则再优质的商业布局,也可能因品控漏洞栽跟头,后续整改能否到位、如何杜绝类似问题,值得行业和消费者持续关注。","news_type":1,"symbols_score_info":{"NVO":1.95}},"isVote":1,"tweetType":1,"viewCount":913,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":20,"optionInvolvedFlag":false,"xxTargetLangEnum":"ZH_CN"},"commentList":[{"id":516086154371408,"commentId":"516086154371408","gmtCreate":1767018326207,"gmtModify":1767019094194,"authorId":3499086704993883,"author":{"id":3499086704993883,"idStr":"3499086704993883","authorId":3499086704993883,"name":"逐梦飞翔","avatar":"https://static.tigerbbs.com/ca5c9bb1da5a4622b93d9781e65477d0","vip":1,"currentWearingBadge":{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-4","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"明星虎友","description":"加入老虎社区2000天","bigImgUrl":"https://static.tigerbbs.com/dddf24b906c7011de2617d4fb3f76987","smallImgUrl":"https://static.tigerbbs.com/53d58ad32c97254c6f74db8b97e6ec49","grayImgUrl":"https://static.tigerbbs.com/6304700d92ad91c7a33e2e92ec32ecc1","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.02.26","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1001},"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":516066543514032,"objectIdStr":"516066543514032","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"这都以前老旧故事了","text":"这都以前老旧故事了","html":"这都以前老旧故事了","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0,"disclaimerType":0}],"isCommentEnd":false,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/516066543514032"}
精彩评论